Filtros : "Bou-Chacra, Nadia Araci" "FCF-FBF" Limpar

Filtros



Limitar por data


  • Fonte: Pharmaceutics. Unidade: FCF

    Assuntos: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 03 out. 2024.
    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
  • Fonte: Nanomedicine. Unidades: FM, FCFRP, FCF

    Assuntos: LEISHMANIA, SISTEMA LINFÁTICO

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Aline de et al. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, v. 19, n. 4, p. 293-301, 2024Tradução . . Disponível em: https://dx.doi.org/10.2217/nnm-2023-0263. Acesso em: 03 out. 2024.
    • APA

      Souza, A. de, Scarim, C. B., Cotrim, P. C., Barbosa Junior, F., Rocha, B. A., Calixto, L. A., et al. (2024). Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, 19( 4), 293-301. doi:10.2217/nnm-2023-0263
    • NLM

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
    • Vancouver

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
  • Fonte: Pharmaceutics. Unidade: FCF

    Assuntos: FARMACOCINÉTICA, BIODISPONIBILIDADE

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MACEDO, Luiza de Oliveira e MASIERO, Jéssica Fagionato e BOU-CHACRA, Nadia Araci. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, v. 16, n. 9, p. 1-21 art. 1141, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16091141. Acesso em: 03 out. 2024.
    • APA

      Macedo, L. de O., Masiero, J. F., & Bou-Chacra, N. A. (2024). Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, 16( 9), 1-21 art. 1141. doi:10.3390/pharmaceutics16091141
    • NLM

      Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141
    • Vancouver

      Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141
  • Fonte: AAPS PharmSciTech. Unidade: FCF

    Assuntos: MEDICAÇÃO ORAL, VASOS LINFÁTICOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Novel first-generation dissolution models to investigate the release and uptake of oral Lymphotropic drug products. AAPS PharmSciTech, v. 25, p. 1-9 art. 187, 2024Tradução . . Disponível em: https://dx.doi.org/10.1208/s12249-024-02866-y. Acesso em: 03 out. 2024.
    • APA

      Yousef, M., Park, C., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2024). Novel first-generation dissolution models to investigate the release and uptake of oral Lymphotropic drug products. AAPS PharmSciTech, 25, 1-9 art. 187. doi:10.1208/s12249-024-02866-y
    • NLM

      Yousef M, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Novel first-generation dissolution models to investigate the release and uptake of oral Lymphotropic drug products [Internet]. AAPS PharmSciTech. 2024 ; 25 1-9 art. 187.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.1208/s12249-024-02866-y
    • Vancouver

      Yousef M, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Novel first-generation dissolution models to investigate the release and uptake of oral Lymphotropic drug products [Internet]. AAPS PharmSciTech. 2024 ; 25 1-9 art. 187.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.1208/s12249-024-02866-y
  • Fonte: Journal of Drug Delivery Science and Technology. Unidades: IQ, FCF, IGC

    Assuntos: SURFACTANTES, TECNOLOGIA FARMACÊUTICA, TENSOATIVOS

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PEREIRA, Érika Aparecida Mol et al. Biosurfactants as stabilizers of niclosamide nanocrystals: enhancing stability, solubility, and cytotoxicity profiling. Journal of Drug Delivery Science and Technology, v. 100, n. , p. 106095-, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.jddst.2024.106095. Acesso em: 03 out. 2024.
    • APA

      Pereira, É. A. M., Santos, M. da S. C. S., Piedade, M. E. M. da, Faria, R. de O., Souza, G. B. de, Lameu, C., et al. (2024). Biosurfactants as stabilizers of niclosamide nanocrystals: enhancing stability, solubility, and cytotoxicity profiling. Journal of Drug Delivery Science and Technology, 100( ), 106095-. doi:10.1016/j.jddst.2024.106095
    • NLM

      Pereira ÉAM, Santos M da SCS, Piedade MEM da, Faria R de O, Souza GB de, Lameu C, Barbosa EJ, Bou-Chacra NA, Lourenço FR, Bezzon VDN, Carvalho FM de S, Araujo GLB de. Biosurfactants as stabilizers of niclosamide nanocrystals: enhancing stability, solubility, and cytotoxicity profiling [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 100( ): 106095-.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.jddst.2024.106095
    • Vancouver

      Pereira ÉAM, Santos M da SCS, Piedade MEM da, Faria R de O, Souza GB de, Lameu C, Barbosa EJ, Bou-Chacra NA, Lourenço FR, Bezzon VDN, Carvalho FM de S, Araujo GLB de. Biosurfactants as stabilizers of niclosamide nanocrystals: enhancing stability, solubility, and cytotoxicity profiling [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 100( ): 106095-.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.jddst.2024.106095
  • Fonte: Industrial Crops and Products. Unidades: FCF, ICB

    Assuntos: NANOPARTÍCULAS, DERMATITE

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MASIERO, Jéssica Fagionato et al. Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design. Industrial Crops and Products, v. 208, p. 1-10 art. 117853, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.indcrop.2023.117853. Acesso em: 03 out. 2024.
    • APA

      Masiero, J. F., Knirsch, M. C., Barreto, T. L., Arantes, G. J., Stephano, M. A., Ishida, K., et al. (2024). Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design. Industrial Crops and Products, 208, 1-10 art. 117853. doi:10.1016/j.indcrop.2023.117853
    • NLM

      Masiero JF, Knirsch MC, Barreto TL, Arantes GJ, Stephano MA, Ishida K, Löbenberg R, Bou-Chacra NA. Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design [Internet]. Industrial Crops and Products. 2024 ; 208 1-10 art. 117853.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.1016/j.indcrop.2023.117853
    • Vancouver

      Masiero JF, Knirsch MC, Barreto TL, Arantes GJ, Stephano MA, Ishida K, Löbenberg R, Bou-Chacra NA. Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design [Internet]. Industrial Crops and Products. 2024 ; 208 1-10 art. 117853.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.1016/j.indcrop.2023.117853
  • Fonte: International Journal of Pharmaceutics. Unidade: FCF

    Assuntos: FÁRMACOS, ANTI-HELMÍNTICOS

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, v. 632, p. 1-9 art. 122554, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122554. Acesso em: 03 out. 2024.
    • APA

      Yukuyama, M. N., Zuo, J., Park, C., Yousef, M., Henostroza, M. A. B., Araujo, G. L. B. de, et al. (2023). Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, 632, 1-9 art. 122554. doi:10.1016/j.ijpharm.2022.122554
    • NLM

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554
    • Vancouver

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554
  • Fonte: Research in Pharmaceutical Sciences. Unidade: FCF

    Assuntos: LISOSSOMOS, MEDICAMENTO

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid. Research in Pharmaceutical Sciences, v. 18, n. 1, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.4103/1735-5362.363591. Acesso em: 03 out. 2024.
    • APA

      Yousef, M., Le, T. S., Zuo, J., Park, C., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid. Research in Pharmaceutical Sciences, 18( 1), 1-15. doi:10.4103/1735-5362.363591
    • NLM

      Yousef M, Le TS, Zuo J, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid [Internet]. Research in Pharmaceutical Sciences. 2023 ; 18( 1): 1-15.[citado 2024 out. 03 ] Available from: https://doi.org/10.4103/1735-5362.363591
    • Vancouver

      Yousef M, Le TS, Zuo J, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid [Internet]. Research in Pharmaceutical Sciences. 2023 ; 18( 1): 1-15.[citado 2024 out. 03 ] Available from: https://doi.org/10.4103/1735-5362.363591
  • Fonte: International Journal of Pharmaceutics. Unidade: FCF

    Assuntos: QUIMIOTERAPIA, NEOPLASIAS PULMONARES

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MIYAGI, Mariana Yasue Saito et al. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach. International Journal of Pharmaceutics, v. 644, p. 1-13 art. 123324, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.123324. Acesso em: 03 out. 2024.
    • APA

      Miyagi, M. Y. S., Faria, R. de O., Lameu, C., Souza, G. B. de, Tagami, T., Ozeki, T., et al. (2023). Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach. International Journal of Pharmaceutics, 644, 1-13 art. 123324. doi:10.1016/j.ijpharm.2023.123324
    • NLM

      Miyagi MYS, Faria R de O, Lameu C, Souza GB de, Tagami T, Ozeki T, Bezzon VDN, Yukuyama MN, Bou-Chacra NA, Araujo GLB de. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach [Internet]. International Journal of Pharmaceutics. 2023 ; 644 1-13 art. 123324.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123324
    • Vancouver

      Miyagi MYS, Faria R de O, Lameu C, Souza GB de, Tagami T, Ozeki T, Bezzon VDN, Yukuyama MN, Bou-Chacra NA, Araujo GLB de. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach [Internet]. International Journal of Pharmaceutics. 2023 ; 644 1-13 art. 123324.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123324
  • Fonte: Chemistry Africa. Unidades: FM, FCF

    Assuntos: TRYPANOSOMA CRUZI, FÁRMACOS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Aline de et al. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, v. 6, p. 837-843, 2023Tradução . . Disponível em: https://doi.org/10.1007/s42250-022-00547-6. Acesso em: 03 out. 2024.
    • APA

      Souza, A. de, Almeida, M. K. L. de, Barbosa, J. A., Yukuyama, M. N., Correia, C. de J., Faloppa, A. C. B., et al. (2023). Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, 6, 837-843. doi:10.1007/s42250-022-00547-6
    • NLM

      Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s42250-022-00547-6
    • Vancouver

      Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s42250-022-00547-6
  • Fonte: Resumos. Nome do evento: Simpósio Internacional de Iniciação Científica e Tecnológica da USP/SIICUSP. Unidade: FCF

    Assuntos: FARMACOTÉCNICA, NEOPLASIAS COLORRETAIS

    Acesso à fonteComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MACÁRIO, Guilherme Souza e BOU-CHACRA, Nadia Araci. Nanosuspensão de pirvínio: preparação e caracterização físico-química. 2023, Anais.. São Paulo: Pró-Reitoria de Pesquisa da USP, 2023. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 03 out. 2024.
    • APA

      Macário, G. S., & Bou-Chacra, N. A. (2023). Nanosuspensão de pirvínio: preparação e caracterização físico-química. In Resumos. São Paulo: Pró-Reitoria de Pesquisa da USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
    • NLM

      Macário GS, Bou-Chacra NA. Nanosuspensão de pirvínio: preparação e caracterização físico-química [Internet]. Resumos. 2023 ;[citado 2024 out. 03 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
    • Vancouver

      Macário GS, Bou-Chacra NA. Nanosuspensão de pirvínio: preparação e caracterização físico-química [Internet]. Resumos. 2023 ;[citado 2024 out. 03 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
  • Fonte: Pharmaceutics. Unidade: FCF

    Assuntos: SISTEMA LINFÁTICO, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, v. 2, p. 1-17 art. 2532, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112532. Acesso em: 03 out. 2024.
    • APA

      Yousef, M., Park, C., Henostroza, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, 2, 1-17 art. 2532. doi:10.3390/pharmaceutics15112532
    • NLM

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
    • Vancouver

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
  • Fonte: International Journal of Pharmaceutics. Unidades: FCF, ICB

    Assuntos: MICROBIOLOGIA, ANTI-INFECCIOSOS, ANTIBIÓTICOS, NANOPARTÍCULAS, SOLUBILIDADE, MICROSCOPIA ELETRÔNICA DE VARREDURA, DOENÇAS INFECCIOSAS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Nataly Paredes da et al. Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug. International Journal of Pharmaceutics, v. 630, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122428. Acesso em: 03 out. 2024.
    • APA

      Rocha, N. P. da, Souza, A. de, Yukuyama, M. N., Barreto, T. L., Macedo, L. de O., Löbenberg, R., et al. (2023). Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug. International Journal of Pharmaceutics, 630, 1-12. doi:10.1016/j.ijpharm.2022.122428
    • NLM

      Rocha NP da, Souza A de, Yukuyama MN, Barreto TL, Macedo L de O, Löbenberg R, Araújo GLB de, Ishida K, Bou-Chacra NA. Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug [Internet]. International Journal of Pharmaceutics. 2023 ; 630 1-12.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122428
    • Vancouver

      Rocha NP da, Souza A de, Yukuyama MN, Barreto TL, Macedo L de O, Löbenberg R, Araújo GLB de, Ishida K, Bou-Chacra NA. Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug [Internet]. International Journal of Pharmaceutics. 2023 ; 630 1-12.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122428
  • Fonte: Journal of Cluster Science. Unidades: FCF, IQ

    Assuntos: ANTI-HELMÍNTICOS, NEOPLASIAS PULMONARES

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GONÇALVES, Debora de Souza et al. Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice. Journal of Cluster Science, v. 34, n. 1, p. 262-272, 2023Tradução . . Disponível em: https://doi.org/10.1007/s10876-022-02220-x. Acesso em: 03 out. 2024.
    • APA

      Gonçalves, D. de S., Yukuyama, M. N., Miyagi, M. Y. S., Silva, T. J. V., Lameu, C., Bou-Chacra, N. A., & Araujo, G. L. B. de. (2023). Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice. Journal of Cluster Science, 34( 1), 262-272. doi:10.1007/s10876-022-02220-x
    • NLM

      Gonçalves D de S, Yukuyama MN, Miyagi MYS, Silva TJV, Lameu C, Bou-Chacra NA, Araujo GLB de. Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice [Internet]. Journal of Cluster Science. 2023 ; 34( 1): 262-272.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s10876-022-02220-x
    • Vancouver

      Gonçalves D de S, Yukuyama MN, Miyagi MYS, Silva TJV, Lameu C, Bou-Chacra NA, Araujo GLB de. Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice [Internet]. Journal of Cluster Science. 2023 ; 34( 1): 262-272.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s10876-022-02220-x
  • Fonte: Journal of Drug Delivery Science and Technology. Unidades: FCF, ESALQ, IQ

    Assuntos: ANTINEOPLÁSICOS, MICROTÚBULOS, NANOTECNOLOGIA, NEOPLASIAS PULMONARES

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment. Journal of Drug Delivery Science and Technology, v. 89, p. 1-14 art. 105017, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105017. Acesso em: 03 out. 2024.
    • APA

      Yukuyama, M. N., Souza, A. de, Henostroza, M. A. B., Araujo, G. L. B. de, Löbenberg, R., Faria, R. de O., et al. (2023). Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment. Journal of Drug Delivery Science and Technology, 89, 1-14 art. 105017. doi:10.1016/j.jddst.2023.105017
    • NLM

      Yukuyama MN, Souza A de, Henostroza MAB, Araujo GLB de, Löbenberg R, Faria R de O, Souza GB de, Guimarães LMF, Lameu C, Folchini BR, Peroni CM, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 89 1-14 art. 105017.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105017
    • Vancouver

      Yukuyama MN, Souza A de, Henostroza MAB, Araujo GLB de, Löbenberg R, Faria R de O, Souza GB de, Guimarães LMF, Lameu C, Folchini BR, Peroni CM, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 89 1-14 art. 105017.[citado 2024 out. 03 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105017
  • Fonte: Applied Chemical Engineering. Unidade: FCF

    Assuntos: LIPOPROTEÍNAS, SISTEMA LINFÁTICO

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications. Applied Chemical Engineering, v. 6, n. 2, p. 1-7, 2023Tradução . . Disponível em: https://doi.org/10.24294/ace.v6i2.2202. Acesso em: 03 out. 2024.
    • APA

      Yousef, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications. Applied Chemical Engineering, 6( 2), 1-7. doi:10.24294/ace.v6i2.2202
    • NLM

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications [Internet]. Applied Chemical Engineering. 2023 ; 6( 2): 1-7.[citado 2024 out. 03 ] Available from: https://doi.org/10.24294/ace.v6i2.2202
    • Vancouver

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications [Internet]. Applied Chemical Engineering. 2023 ; 6( 2): 1-7.[citado 2024 out. 03 ] Available from: https://doi.org/10.24294/ace.v6i2.2202
  • Fonte: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Assuntos: MEDICAMENTO, ANTIRRETROVIRAIS, HIV

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Nataly Paredes da et al. Statistical process control of manufacturing tablets for antiretroviral therapy. Brazilian Journal of Pharmaceutical Sciences, v. 59, p. 1-19 art. e22099, 2023Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902023e22099. Acesso em: 03 out. 2024.
    • APA

      Rocha, N. P. da, Silva, O. C. da, Barbosa, E. J., Soares, G., Oliveira, R., Monteiro, L. M., & Bou-Chacra, N. A. (2023). Statistical process control of manufacturing tablets for antiretroviral therapy. Brazilian Journal of Pharmaceutical Sciences, 59, 1-19 art. e22099. doi:10.1590/s2175-97902023e22099
    • NLM

      Rocha NP da, Silva OC da, Barbosa EJ, Soares G, Oliveira R, Monteiro LM, Bou-Chacra NA. Statistical process control of manufacturing tablets for antiretroviral therapy [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2023 ; 59 1-19 art. e22099.[citado 2024 out. 03 ] Available from: https://doi.org/10.1590/s2175-97902023e22099
    • Vancouver

      Rocha NP da, Silva OC da, Barbosa EJ, Soares G, Oliveira R, Monteiro LM, Bou-Chacra NA. Statistical process control of manufacturing tablets for antiretroviral therapy [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2023 ; 59 1-19 art. e22099.[citado 2024 out. 03 ] Available from: https://doi.org/10.1590/s2175-97902023e22099
  • Unidade: FCF

    Assuntos: BACTÉRIAS, ANTIBIÓTICOS

    Acesso à fonteComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BOU-CHACRA, Nadia Araci e HENOSTROZA, Mirla Anali Bazan. Formulação nanoestruturada para infecção bacteriana ocular. . São Paulo: Agência USP de Inovação/AUSPIN. Disponível em: http://patentes.usp.br/tech?title=FORMULA%c3%87%c3%83O_NANOESTRUTURADA_PARA_I NFEC%c3%87%c3%83O_BACTERIANA_OCULAR. Acesso em: 03 out. 2024. , 2022
    • APA

      Bou-Chacra, N. A., & Henostroza, M. A. B. (2022). Formulação nanoestruturada para infecção bacteriana ocular. São Paulo: Agência USP de Inovação/AUSPIN. Recuperado de http://patentes.usp.br/tech?title=FORMULA%c3%87%c3%83O_NANOESTRUTURADA_PARA_I NFEC%c3%87%c3%83O_BACTERIANA_OCULAR
    • NLM

      Bou-Chacra NA, Henostroza MAB. Formulação nanoestruturada para infecção bacteriana ocular [Internet]. 2022 ;[citado 2024 out. 03 ] Available from: http://patentes.usp.br/tech?title=FORMULA%c3%87%c3%83O_NANOESTRUTURADA_PARA_I NFEC%c3%87%c3%83O_BACTERIANA_OCULAR
    • Vancouver

      Bou-Chacra NA, Henostroza MAB. Formulação nanoestruturada para infecção bacteriana ocular [Internet]. 2022 ;[citado 2024 out. 03 ] Available from: http://patentes.usp.br/tech?title=FORMULA%c3%87%c3%83O_NANOESTRUTURADA_PARA_I NFEC%c3%87%c3%83O_BACTERIANA_OCULAR
  • Fonte: Drugs Drug Candidates. Unidade: FCF

    Assuntos: TRYPANOSOMA CRUZI, LEISHMANIA, NANOTECNOLOGIA

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SCARIM, Cauê Benito et al. Synthesis, characterization, and activity of hydroxymethylnitrofurazone nanocrystals against Trypanosoma cruzi and Leishmania spp. Drugs Drug Candidates, v. 1, p. 43–55, 2022Tradução . . Disponível em: https://doi.org/10.3390/ddc1010005. Acesso em: 03 out. 2024.
    • APA

      Scarim, C. B., Souza, A. de, Marins, D. S. S., Santos, E. G. dos, Castro, L. de F. D., Caldas, I. S., et al. (2022). Synthesis, characterization, and activity of hydroxymethylnitrofurazone nanocrystals against Trypanosoma cruzi and Leishmania spp. Drugs Drug Candidates, 1, 43–55. doi:10.3390/ddc1010005
    • NLM

      Scarim CB, Souza A de, Marins DSS, Santos EG dos, Castro L de FD, Caldas IS, Espuri PF, Marques MJ, Ferreira EI, Bou-Chacra NA, Chin CM. Synthesis, characterization, and activity of hydroxymethylnitrofurazone nanocrystals against Trypanosoma cruzi and Leishmania spp [Internet]. Drugs Drug Candidates. 2022 ; 1 43–55.[citado 2024 out. 03 ] Available from: https://doi.org/10.3390/ddc1010005
    • Vancouver

      Scarim CB, Souza A de, Marins DSS, Santos EG dos, Castro L de FD, Caldas IS, Espuri PF, Marques MJ, Ferreira EI, Bou-Chacra NA, Chin CM. Synthesis, characterization, and activity of hydroxymethylnitrofurazone nanocrystals against Trypanosoma cruzi and Leishmania spp [Internet]. Drugs Drug Candidates. 2022 ; 1 43–55.[citado 2024 out. 03 ] Available from: https://doi.org/10.3390/ddc1010005
  • Fonte: AAPS PharmSciTech. Unidade: FCF

    Assuntos: ANTI-INFLAMATÓRIOS, FÁRMACOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HAJJAR, Braa et al. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, v. 23, p. 1-9 art. 102, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02258-0. Acesso em: 03 out. 2024.
    • APA

      Hajjar, B., Zuo, J., Park, C., Azarmi, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, 23, 1-9 art. 102. doi:10.1208/s12249-022-02258-0
    • NLM

      Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 out. 03 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
    • Vancouver

      Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 out. 03 ] Available from: https://doi.org/10.1208/s12249-022-02258-0

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024